Company page

Infant Bacterial Therapeutics Ab Class B

Infant Bacterial Therapeutics AB Class B, trading under the ticker IBT_B, is a public company based in Sweden. The company has a market capitalization of approximately 79.8 million USD. It focuses on developing innovative treatments for infant health, particularly in the area of bacterial therapies.